Mercury

Mercury Fund is an early-stage venture capital firm based in Houston, Texas, with an additional office in Ann Arbor. Established in 2005, the firm manages over $200 million and focuses on investing in technology-related startups in the U.S. Midcontinent. Mercury targets companies within sectors such as software as a service (SaaS), cloud computing, data, and artificial intelligence. The firm supports both new entrepreneurs in need of guidance and experienced founders looking to capitalize on the resources available in Middle America. Mercury has gained recognition as a prominent venture capital partner for entrepreneurs who have achieved product-market fit and are poised for growth.

Taylor Anne Adams

Associate

Heath Butler

Managing Director

Peter Commons

Partner

Alex Gras

Associate

Nafisa Istami

Analyst

Edward Lou

Venture Partner

Adrienne Miller

Associate

Patrick Okorafor

Director of Finance

Devin Redmond

Senior Associate

Dan Watkins

Venture Partner

Past deals in Colorado

Clean Chemistry

Debt Financing in 2016
Clean Chemistry is a biotechnology company that specializes in the field of water management and water purification. It develops oxidant chemistries based on activated oxygen in liquid formulations for water treatment, reuse, and recycling, particularly for use in hydraulic fracturing and enhanced oil recovery processes. The company was incorporated in 2012 and is based in Boulder, Colorado.

Sinopsys Surgical

Debt Financing in 2016
Sinopsys Surgical, Inc. specializes in developing medical devices aimed at treating chronic sinus disease (CRS) and enhancing surgical procedures for the lacrimal glands. The company manufactures innovative products such as the Sinopsys Lacrimal Stent (SLS) and the Lacrimal Ethmoid Access Procedure (LEAP). Established in 2011 and headquartered in Boulder, Colorado, Sinopsys Surgical was previously known as DCS Surgical, Inc. Through its advanced technologies, the company seeks to improve patient outcomes in sinus-related surgeries.

Apto

Venture Round in 2016
Apto is a web-based broker software for managing contacts, properties, listings, and deals for the commercial real estate industry. Its platform streamlines the full lifecycle of deals from prospect to close with sales tools that put their data to work and make sure no details fall through the cracks to consolidate, organize and securely store contact and property data in the cloud, that enables clients to find, win, and execute deals more efficiently and effectively. Apto was established in 2012 and is headquartered in Denver, Colorado.

Apto

Series B in 2015
Apto is a web-based broker software for managing contacts, properties, listings, and deals for the commercial real estate industry. Its platform streamlines the full lifecycle of deals from prospect to close with sales tools that put their data to work and make sure no details fall through the cracks to consolidate, organize and securely store contact and property data in the cloud, that enables clients to find, win, and execute deals more efficiently and effectively. Apto was established in 2012 and is headquartered in Denver, Colorado.

Apto

Series A in 2014
Apto is a web-based broker software for managing contacts, properties, listings, and deals for the commercial real estate industry. Its platform streamlines the full lifecycle of deals from prospect to close with sales tools that put their data to work and make sure no details fall through the cracks to consolidate, organize and securely store contact and property data in the cloud, that enables clients to find, win, and execute deals more efficiently and effectively. Apto was established in 2012 and is headquartered in Denver, Colorado.

Clean Chemistry

Series A in 2014
Clean Chemistry is a biotechnology company that specializes in the field of water management and water purification. It develops oxidant chemistries based on activated oxygen in liquid formulations for water treatment, reuse, and recycling, particularly for use in hydraulic fracturing and enhanced oil recovery processes. The company was incorporated in 2012 and is based in Boulder, Colorado.

Sinopsys Surgical

Debt Financing in 2013
Sinopsys Surgical, Inc. specializes in developing medical devices aimed at treating chronic sinus disease (CRS) and enhancing surgical procedures for the lacrimal glands. The company manufactures innovative products such as the Sinopsys Lacrimal Stent (SLS) and the Lacrimal Ethmoid Access Procedure (LEAP). Established in 2011 and headquartered in Boulder, Colorado, Sinopsys Surgical was previously known as DCS Surgical, Inc. Through its advanced technologies, the company seeks to improve patient outcomes in sinus-related surgeries.

Techstars

Venture Round in 2011
Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, is a startup accelerator that focuses on incubating and investing in early-stage technology companies across various sectors, particularly fintech, retail technology, artificial intelligence, augmented reality, blockchain, and Internet of Things. The organization operates several accelerator programs worldwide, including specialized initiatives like Techstars Music and Techstars Retail Accelerator, which support startups in the music industry and retail sector, respectively. Each program typically lasts three months and selects ten companies to receive funding and mentorship, often providing investments ranging from $0.01 million to $0.12 million in exchange for equity. Techstars also emphasizes a global reach, investing in companies from diverse regions, including Africa, Asia, and Latin America. The firm does not seek board representation or investor rights in its portfolio companies, preferring to take minority stakes. Through its extensive network, Techstars connects entrepreneurs with mentors, investors, and corporate partners to foster growth and innovation in the startup ecosystem.

X-Sten

Series A in 2005
X-Sten Corp., an Englewood, Colo.-based medical device startup.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.